day 1 agenda
| Scientific Program | ||
| Day -1: July (07, 2025) | ||
| Meeting Hall - 1 | ||
| Registrations Open (08:00-08:50) | ||
| Opening Ceremony (08:50-09:00) | ||
| Keynote Talks | ||
| Mohamed El-Far, Mansoura University, Egypt |
09:00-09:30 | Title: Photodynamic therapy of tumors by Lasers from our bench discovery to clinical applications: Future perspective of using it in combination with our novel naturally derived nanoformulations as advancement therapy of cancer |
| Thomas Boldicke, Helmholtz Centre for Infection Research, Germany |
09:30-10:10 | Title: The future of cancer immunotherapy with recombinant T-cells and recombinant antibodies |
| TBA | 10:10-10:40 | TBA |
| Group Photo & Refreshment Break (10:40-11:00) | ||
| Scientific Session I | ||
| Morning Session: | ||
| Jennie R Lill, Genentech Inc., United States |
11:00-11:20 | Title: TEAD-targeting small molecules trigger a cofactor switch to modulate the Hippo pathway |
| Maria J Nieto, Northwell Health Cancer Institute, United States |
11:20-11:40 | Title: AL Amyloidosis: A review of the literature |
| Speaker slot available | 11:40-12:00 | Speaker slot available |
| Fotios Mpekris, University of Cyprus, Cyprus |
12:00-12:20 | Title: Combination of two approaches to modify the tumor microenvironment and enhance the effectiveness of nano-immunotherapy |
| Hui Zhang & Hong Sun, University of Nevada, United States |
12:20-12:50 | Title: Regulation of Hematopoiesis by A Methylation-Phosphorylation Switch in PRC2/EZH2 |
| Kyle Cowan, Children's Hospital of Eastern Ontario, Canada |
12:50-13:10 | Title: APOBEC2: Its role in the pannexin 1-mediated inhibition of rhabdomyosarcoma progression and potential as a novel therapeutic target |
| (13:10-14:00) Lunch Break @ Restaurant | ||
| Scientific Session II | ||
| Afternoon Session: | ||
| James Boyt, University of South Carolina, United States |
14:00-14:20 | Title: Development of a liquid biopsy: evaluating aberrant glycosylation in secreted and membrane glycoproteins |
| Esin Sevgi Dogan, Manisa Celal Bayar University, Turkey |
14:20-14:40 | Title: Knowledge, attitudes, and beliefs regarding skin cancer among health sciences students in Turkey: A cross-sectional study |
| Seront Emmanuel, Cliniques universitaires Saint Luc, Belgium |
14:40-15:00 | Title: Evolving Strategies in the Management of Metastatic Renal Cell Carcinoma: A Practical Guide for Clinicians |
| Speaker slot available | 15:00-15:20 | Speaker slot available |
| Xiaotian Chen, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, China |
15:20-15:40 | Title: The role of sarcopenic obesity for the prediction of prognosis of patients with gastrointestinal cancer |
| Valentin Lecomte, University of Mons, Belgium |
15:40-16:00 | Title: Exploration of the radiosensitising potential of functionalised iron oxide nanoparticles |
| Refreshment Break(16:00-16:10) | ||
| Victor E. Nava, George Washington University , United States |
16:10-16:30 | Title: Advances in Prognostication and Molecular Characterization of Prostatic Carcinoma and the Promise of New Therapeutic Strategies |
| Speaker slot available | 16:30-16:50 | Speaker slot available |
| Kavita Behara, Mangosuthu University of Technology, South africa |
16:50-17:10 | Title: Meta-Graph Attention Model: A Novel Approach for Skin Lesion Classification and Recognition |
| Speaker slot available | 17:10-17:30 | Speaker slot available |
| Pannel Discussions | ||
| Note: This is the tentative program only and the timings may be subject to change | ||
| Conference Hotel: Rainers Hotel Vienna Address: Gudrunstraße 184, 1100 Wien, Austria |
||
| If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com | ||
day 2 agenda
| Scientific Program | ||
| Day -2: July (08, 2025) | ||
| Meeting Hall - 1 | ||
| Keynote Talks | ||
| Mohamed Hassan, Tulane University Schoole of Medicine, United States |
09:30-10:00 | Title: Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells |
| TBA | 10:00-10:30 | TBA |
| Refreshment Break (10:30-10:40) | ||
| Scientific Session III | ||
| Morning Session: | ||
| Najib Dally, Ziv Medical Center, Israel |
10:40-11:00 | Title: Ethnic disparities in presentation not outcome in multiple myeloma patients: a multicenter retrospective study in Northern Israel |
| Shunfu Hu, Southern Illinois University, United States |
11:00-11:20 | Title: Examining the Impact of Socio-demographic and Macro-environmental Factors on Cancer Mortality Rates in 2020 in Illinois, USA |
| Ting-Ting Ma, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, China |
11:20-11:40 | Title: Scutellaria barbata D.Don and Scleromitrion diffusum (Willd.) R.J.Wang inhibits the progression of triple negative breast cancer though the activation inhibition of NF-κB triggered by CAFs-derived IL6 |
| Maria Braoudaki, University of Hertfordshire, United kingdom |
11:40-12:00 | Title: Tumour suppressive roles of miR-206 and miR-383 via CORO1C and SV2B in aggressive adult brain malignancies |
| Speaker slot available | 12:00-12:20 | Speaker slot available |
| Fangzhou Liu, Nanjing Medical University, China |
12:20-12:40 | Title: Transcription factor DDIT3 is a potential driver in pancreatic cancer |
| Speaker slot available | 12:40-13:00 | Speaker slot available |
| (13:00-14:00) Lunch Break @ Restaurant | ||
| Afternoon Session: | ||
| Poster presentations (14:00-14:40) | ||
| Scientific Session IV | ||
| Bat Chen R. Lubin, Eastern R&D center, Israel |
14:40-15:00 | Title: Targeting EGFR using cyclic peptide for the treatment of EGFR overexpressed cancer |
| Shiwen Luo, The First Affiliated Hospital of Nanchang University, China |
15:00-15:20 | Title: LncRNA HOTTIP modulated by Hedgehog signaling drives colorectal cancer progression by promoting HUWE1-mediated ubiquitin-proteasome degradation of p53 |
| Sergiu Scobioala, University Hospital of Muenster, Germany |
15:20-15:40 | Title: Risk factors for therapy-related sensorineural hearing loss and hearing aid use in medulloblastoma patients: an observational cohort study |
| Speaker slot available | 15:40-16:00 | Speaker slot available |
| Keyu Li, Sichuan University, China |
16:00-16:20 | Title: Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration |
| Refreshment Break (16:20-16:30) | ||
| Speaker slot available | 16:30-16:50 | Speaker slot available |
| Speaker slot available | 16:50-17:10 | Speaker slot available |
| Speaker slot available | 17:10-17:30 | Speaker slot available |
| Poster presentations (14:00-14:40) | ||
| Yi Wang, Children’s Hospital of Soochow University, China |
WCCRT-I | Title: Clinical Analysis of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Children |
| Stephanie Langlois, Children's Hospital of Eastern Ontario, Canada |
WCCRT-II | Title: Targeting pannexin 1 to inhibit the malignant properties of human high-risk neuroblastoma: potential for drug repurposing |
| Jinli Wang, Shenzhen Hospital, Beijing University of Chinese Medicine, United States |
WCCRT-III | Title: Chemotherapy-mediated IncRNA-induced immune cell plasticity in cancer immunopathogenesis |
| Kavitha UK, RGCB Thiruvananthapuram, India |
WCCRT-IV | Title: Therapeutic Targeting of Triple Negative Breast Cancer Using Engineered Small Extracellular Vesicles for Delivery of miRNA-204-5p |
| Weijie Zang, Affiliated Hospital of Nantong University, China |
WCCRT-V | Title: The cancer-testis lncRNA LINC01940 contributes to gastric cancer progression and chemoresistance through NOL11-dependent ribosome biogenesis |
| Juan He, Jiaxing University, China |
WCCRT-VI | Title: The Nursing Value of Individualized Comprehensive Nursing Model in Patients with Pancreatic Cancer |
| Xiaoping Li, Jiaxing University, China |
WCCRT-VII | Title: The Effect of ERAS Nursing Model of Multidisciplinary Collaboration Based on Stress Theory on the Prognosis of Patients with Gastric Cancer after Surgery |
| Qinjie Guo, Jiaxing University, China |
WCCRT-VIII | Title: Study on nursing standardization in the treatment of patients with liver cancer |
| Xinyi Kong, Jiaxing University, China |
WCCRT-IX | Title: Explore the Application of Nursing Subspecialty Management Model Oriented by High-quality Holistic Nursing in Patients with Early Pancreatic Cancer after Surgery |
| Pannel Discussions | ||
| Note: This is the tentative program only and the timings may be subject to change | ||
| Closing Ceremony | ||
| Conference Hotel: Rainers Hotel Vienna Address: Gudrunstraße 184, 1100 Wien, Austria |
||
| If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com | ||
Virtual Agenda
| Scientific Program | ||
| Day -2: July (08, 2025) | ||
| Virtual Presentations (Time zone: CET) | ||
| Jianshu Lou, Hangzhou normal University, China |
10:00-10:20 | Title: TFEB promotes GK induced ferroptosis via promoting TRIM25 mediated GPX4 lysosome degradation in EGFR wide-type lung adenocarcinoma |
| Speaker slot available | 10:20-10:40 | Speaker slot available |
| Biwen Zhu, Nantong University School of Medicine, China |
10:40-11:00 | Title: Matrix stiffness mediates hepatic stellate cell activation via Piezo1 and reprogramming pancreatic cancer cell lipid metabolism to regulate pancreatic cancer liver metastasis |
| Speaker slot available | 11:00-11:20 | Speaker slot available |
| Lizhu Chen, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, China |
11:20-11:40 | Title: Network pharmacology and molecular docking approach to elucidate the mechanisms of safflower, phellodendron, scutellaria baicalensis, coptis, and gardenia in hand–foot syndrome |
| Speaker slot available | 11:40-12:00 | Speaker slot available |
| Maocai Tang, Chongqing University Cancer Hospital, China |
12:00-12:20 | Title: The Comparative Study of Indocyanine Green and Carbon Nanoparticle Suspension Injection for Lymph Node Tracing in Laparoscopic Radical Gastrectomy for Gastric Cancer |
| Saumya Gupta, Amrita Institute of medical sciences, India |
12:20-12:40 | Title: Clinical usefulness of Fagotti’s Predictive Index Value, and its correlation with CT based Peritoneal Cancer Index: experience from a tertiary care oncology center in South India |
| Wafaa Mostafa AbdElGawad, Kuwait Palliative Care Center, MOH, Kuwait |
12:40-13:00 | Title: Early integration of Palliative Care into oncology Practice in Kuwait Between Dream and Reality |
| Jenan Issa, Applied science university, Jordan |
13:00-13:20 | Title: Allicin and cancer hallmarks |
| Speaker slot available | 13:20-13:40 | Speaker slot available |
| Jekaterina Ivanova, Latvian Institute of Organic Synthesis, Latvia |
13:40-14:00 | Title: Inhibitors of selenoenzyme TrxR as anti-cancer agents – synthesis and biological evaluation |
| Aleksandrs Pustenko, Latvian Institute of Organic Synthesis, Latvia |
14:00-14:20 | Title: Thiazine 1,1-dioxide derivatives as potencial anticancer agents |
| Speaker slot available | 14:20-14:40 | Speaker slot available |
| Nasrin Fares Amer, University of Haifa, Israel |
14:40-15:00 | Title: Natural Product from Asparagopsis taxiformis for Targeting Colorectal Cancer |
| Raimundo Fernandes de Araujo Júnior, Universidade Federal do Rio Grande do Norte, Brazil |
15:00-15:20 | Title: Extracellular Vesicles (EVs) from macrophages 1 as drugs carriers down-regulate the tumor progression and scape in murine colorectal cancer |
| Speaker slot available | 15:20-15:40 | Speaker slot available |
| Melinda Ildiko Mitranovici, ESHRE,ISSVD, Romania |
15:40-16:00 | Title: Cancer stemness: therapeutic and prognostic perspective in gynecology |
| Speaker slot available | 16:00-16:20 | Speaker slot available |
| Chan Zhou, University of Massachusetts Chan Medical School, United States |
16:20-16:40 | Title: Flnc: Machine Learning Improves the Identification of Novel Long Noncoding RNAs from Stand-Alone RNA-Seq Data |
| Speaker slot available | 16:40-17:00 | Speaker slot available |
| Theodoros Karantanos, Johns Hopkins University, United States |
17:00-17:20 | Title: New insights into the biology and treatment of TP53 mutated myeloid neoplasms |
| Nikita Nikita, Thomas Jefferson University, United States |
17:20-17:40 | Title: The rates of septicemia in older adults with prostate cancer treated with abiraterone or enzalutamide: A population-based study |
| Closing Ceremony | ||
| Note: This is the tentative program only and the timings may be subject to change | ||
| If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com | ||